Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 3, 2003, Pages 167-174

  Davis, G K ^a  

^a NONE

Author keywords

Cardiac troponin; Myocardial damage; Prognosis; PTCA

Indexed keywords

CREATINE KINASE MB; TROPONIN I; TROPONIN T;

CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIAGNOSTIC ACCURACY; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0038468640     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310001140     Document Type: Review

References (43)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959-69.
2. Wu AHB, Valdes R Jr, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, Ingersoll AM, Wiler B. Cardiac troponin T immunoassay for diagnosis of acute myocardial infarction and detection of minor myocardial injury. Clin Chem 1994; 40: 900-7.
3. Mair J, Morandel D, Genser N, Lechleitner P, Dientsl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, Creatine kinase isoform ratios and cardiac troponin I and T for acute myocardial infarction. Clin Chem 1995; 41: 1266-72.
4. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-63.
5. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. It's time for a change to a troponin standard. Circulation 2000; 102: 1216-20.
6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE III, Steward DE, Theroux P, Gibbons RJ, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193-209.
7. Apple FS, Falahati A, Paulsen PR, Miller EA, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem 1997; 43: 2047-51.
8. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-7.
9. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Salter LF, Kent KM, Stone GW, Leon MB. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions intravascular ultrasound study of 2256 patients. Circulation 2000; 101: 604-10.
10. Hunt AC, Chow SL, Shu MF, Chilton DC, Cummins B, Cummins P. Release of creatine kinase - MB and cardiac specific troponin-I following percutaneous transcoronary angioplasty. Eur Heart J 1991; 12: 690-4.
11. Katoh H, Shimada T, Sano K, Inove S, Kitamura J, Sakane T, Murakami Y, Ishibashi Y, Karino K, Masuda J. Troponin T in the coronary sinus and percutaneous transluminal coronary angioplasty related myocardial injury. Clin Exp Pharmacol Physiol 2000; 27: 14-7.
12. Ravkilde J, Nissen H, Mickley H, Andersen P, Thayssen P, Horder M. Cardiac troponin T and CK MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127: 13-9.
13. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon M. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device specific analysis of 7147 patients. Circulation 2001; 104: 642-7.
14. Abbas SA, Glazier JJ, Wu AH, Dupont C, Green SF, Pearsall LA, Waters DD, McKay RG. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol 1996; 19: 782-6.
15. Bonz AW, Lengenfelder B, Strotmann J, Held S, Turschner O, Harre K, Wacker C, Walker C, Kochsiek N, Meesmann M, Neyses L, Schanzenbacher P, Ertl G, Voelker W. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOP-STAR trial). J Am Coll Cardiol 2002; 40: 662-8.
16. Baim D, Wahr D, George B, Leon M, Greenberg J, Cutlip D, Kaya U, Popma J, Ho K. Kuntz Ron behalf of the saphenous vein graft angioplasty free of emboli randomized (SAFER) trial investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002; 105: 1285-90.
17. Chan AW, Quinn MJ, Bhatt DL, Chew DP, Moliterno DJ, Topol EJ, Ellis GS. Mortality benefit of beta-blockade after elective percutaneous coronary intervention. J Am Coll Cardiol 2002; 40: 669-75.
18. Johansen O, Brekke M, Stromme JH, Valen V, Seljeflot I, Skjaeggestad O, Arnesen. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur Heart J 1998; 19: 112-7.
19. Stromme JH, Johansen O, Brekke M, Seljeflot I, Arnesen H. Markers of myocardial injury in blood following PTCA: a comparison of CK MB, cardio-specific troponin T and troponin I. Scand J Clin Lab Invest 1998; 58: 693-700.
20. Karim M, Shinn M, Oskarsson H, Windle J, Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1995; 76: 521-3.
21. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins. Catheter Cardiovasc Interv 2001; 53: 188-92.
22. Talasz H, Genser N, Mair J, Dworzak E, Friedrich G, Moes N, Muhlberger VC, Puschendorf B. Side-branch occlusion during percutaneous transluminal coronary angioplasty. Lancet 1992; 339: 1380-2.
23. Genser M, Mair J, Talasz H, Puschendorf B, Calzolari C, Larue C, Friedrich G, Moes N, Muehlberger V. Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chim Acta 1997; 265: 207-17.
24. Vecchia L, Bedogni F, Finocchi G, Mezzena G, Martini M, Sartori M, Castellani A, Soffiati G, Vincenzi M. Troponin T, troponin I and creatine kinase - MB mass after elective coronary stenting. Coron Artery Dis 1996; 7: 535-40.
25. Shyu K, Kuan P, Cheng J, Hung C. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J 1998; 135: 862-7.
26. Garbarz E, Iung B, Lefevre G, Makita Y, Farah B, Michaud P, Graine H, Vahanian A. Frequency and prognostic value of cardiac troponin I elevation after stenting. Am J Cardiol 1999; 84: 515-8.
27. Ohnishi N, Iwasaki K, Kusachi S, Hirami R, Mataro S, Ohnishi H, Takeda K, Kita T, Sakakibara N, Tsuji T. Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty. Jpn Heart J 1998; 39: 139-46.
28. Bertinchant J, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84: 51-7.
29. Attali P, Aleil P, Petitpas G, DePoli F, Wuillermin A, Cazenave JP, Mossard JM. Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol 1998; 21: 353-6.
30. Fuchs S, Gruberg L, Singh S, Stabile E, Duncan C, Wu H, Waksman R, Satler LF, Pichard AD, Kent KM, Kornowski R. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes. Am J Cardiol 2001; 88: 129-33.
31. Ricchiuti V, Shear W, Henry T, Paulsen P, Miller E, Apple F. Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty. Clin Chim Acta 2000; 302: 161-70.
32. Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, Urban P, den Heijer P, Koch K, Simon R, Morice MC, Crean P, Bonnier H, Wijns W, Danchin N, Bourdonnec C, Morel MA. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of the Benestent trial. Benestent Study Group. J Am Coll Cardiol 1996; 27: 256-61.
33. Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I CK MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem 2000; 37: 764-9.
34. Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Muller-Bardoff M, Richardt G, Katus HA. Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous intervention for acute ST-segment elevation myocardial infarction. Crit Care Med 2002; 30: 2229-35.
35. Fuchs S, Kornowski R, Mehran R, Lansky J, Satler F, Pichard D, Kent M, Clark E, Stone G, Leon M. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000; 85: 1077-82.
36. Abdelmeguid A, Topol E. The myth of the myocardial "infarctlet" during percutaneous coronary revascularization procedures. Circulation 1996; 94: 3369-75.
37. Akkerhuis K, Alexander J, Tardiff B, Boersma E, Harrington R, Lincoff M, Simoons M. Minor myocardial damage and prognosis, are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002; 105: 554-6.
38. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebter W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-12.
39. Jaffe AS, Landt Y, Parvin CA, Abedschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosis of acute myocardial infarction. Clin Chem 1996; 42: 1770-6.
40. Apple F. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999; 45: 18-20.
41. Katrukha AG, Bereznikova AV, Filatov V, Esakova TV, Kolosova OV, Petterson K, Lovgren T, Bulargina TV, Trifonov IR, Gratsiansky NA, Pulkki K, Voipio-Pulkki LM, Gusev NB. Degradation of cardiac troponin I: implications for reliable immunodetection. Clin Chem 1998; 44: 2433-40.
42. Wu AHB, Feng YJ, Moore R, Apple FS, Mc Pherson PH, Buechler KF, Bodor G. Characterization of cardiac troponin subunit release into serum following acute myocardial infarction, and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on Standardization. Clin Chem 1998; 44: 1198-208.
43. Christenson RH, Duh SH, Apple FS, Bodor G, Bunk DM, Dalluge J, Panteghini M, Potter JD, Welch MJ, Wu AH, Kahn SE. Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin Chem 2001; 47: 431-7.